Today Leerink Swann Reconfirms a “Buy” Rating on CVS Health (NYSE:CVS) and a $85.0 Target Price

February 11, 2018 – By Winifred Garcia

Investors sentiment decreased to 0.88 in Q3 2017. Its down 0.04, from 0.92 in 2017Q2. It dropped, as 60 investors sold CVS Health Corporation shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported.

M Kraus Communications invested in 1.14% or 22,384 shares. Frontier Investment holds 245,006 shares or 1.65% of its portfolio. Strategic Fincl accumulated 0.9% or 66,839 shares. Mcrae Cap Mgmt Incorporated holds 0.11% or 3,100 shares in its portfolio. Cleararc Inc accumulated 26,148 shares. Sheets Smith Wealth Management holds 9,310 shares. Mitchell Mcleod Pugh And Williams reported 0.38% of its portfolio in CVS Health Corporation (NYSE:CVS). Vantage Advisors Limited Liability Com holds 0.05% or 2,610 shares. Sumitomo Life Insurance Company reported 0.25% stake. Jupiter Asset Ltd has 159,815 shares for 0.44% of their portfolio. Yhb Invest Inc accumulated 1.37% or 93,873 shares. Warren Averett Asset Management Limited Company accumulated 18,880 shares or 0.33% of the stock. Wellington Shields Capital Mgmt Lc reported 29,199 shares. Scharf Ltd Liability Corp holds 4.86% or 2.46M shares. Westpac Corp holds 0.12% or 66,195 shares in its portfolio.

Since August 16, 2017, it had 0 buys, and 7 insider sales for $58.32 million activity. Roberts Jonathan C had sold 85,743 shares worth $7.13M on Monday, September 18. Denton David M had sold 237,078 shares worth $18.88 million. $3.22M worth of CVS Health Corporation (NYSE:CVS) shares were sold by Foulkes Helena. 2,500 shares were sold by SWIFT RICHARD J, worth $199,050. Shares for $20.03 million were sold by MERLO LARRY J on Wednesday, August 23.

CVS Health (NYSE:CVS) Rating Reaffirmed

CVS Health (NYSE:CVS) just had their share rating of a ‘”Buy”‘ issued by research analysts at Leerink Swann, who now has a $85.0 TP on the $70.30B market cap company or a 22.50 % upside potential. This key information was revealed to investors in a research report on 7 November.

Investors sentiment decreased to 0.88 in Q3 2017. Its down 0.04, from 0.92 in 2017Q2. It dropped, as 60 investors sold CVS Health Corporation shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported.

M Kraus Communications invested in 1.14% or 22,384 shares. Frontier Investment holds 245,006 shares or 1.65% of its portfolio. Strategic Fincl accumulated 0.9% or 66,839 shares. Mcrae Cap Mgmt Incorporated holds 0.11% or 3,100 shares in its portfolio. Cleararc Inc accumulated 26,148 shares. Sheets Smith Wealth Management holds 9,310 shares. Mitchell Mcleod Pugh And Williams reported 0.38% of its portfolio in CVS Health Corporation (NYSE:CVS). Vantage Advisors Limited Liability Com holds 0.05% or 2,610 shares. Sumitomo Life Insurance Company reported 0.25% stake. Jupiter Asset Ltd has 159,815 shares for 0.44% of their portfolio. Yhb Invest Inc accumulated 1.37% or 93,873 shares. Warren Averett Asset Management Limited Company accumulated 18,880 shares or 0.33% of the stock. Wellington Shields Capital Mgmt Lc reported 29,199 shares. Scharf Ltd Liability Corp holds 4.86% or 2.46M shares. Westpac Corp holds 0.12% or 66,195 shares in its portfolio.

Since August 16, 2017, it had 0 buys, and 7 insider sales for $58.32 million activity. Roberts Jonathan C had sold 85,743 shares worth $7.13M on Monday, September 18. Denton David M had sold 237,078 shares worth $18.88 million. $3.22M worth of CVS Health Corporation (NYSE:CVS) shares were sold by Foulkes Helena. 2,500 shares were sold by SWIFT RICHARD J, worth $199,050. Shares for $20.03 million were sold by MERLO LARRY J on Wednesday, August 23.

CVS Health Corporation (NYSE:CVS) Ratings Coverage

Among 25 analysts covering CVS Health (NYSE:CVS), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. CVS Health has $132 highest and $73 lowest target. $97.10’s average target is 39.93% above currents $69.39 stock price. CVS Health had 71 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of CVS Health Corporation (NYSE:CVS) has “Buy” rating given on Monday, December 4 by Needham. The firm earned “Strong Buy” rating on Monday, November 2 by S&P Research. The firm has “Buy” rating given on Wednesday, August 19 by Evercore. On Monday, December 12 the stock rating was downgraded by Jefferies to “Hold”. RBC Capital Markets maintained CVS Health Corporation (NYSE:CVS) on Thursday, February 8 with “Buy” rating. The firm has “Hold” rating given on Wednesday, October 18 by Jefferies. The firm has “Buy” rating by Mizuho given on Wednesday, January 24. Argus Research maintained CVS Health Corporation (NYSE:CVS) on Monday, August 10 with “Buy” rating. Jefferies maintained CVS Health Corporation (NYSE:CVS) on Wednesday, August 16 with “Hold” rating. JP Morgan maintained CVS Health Corporation (NYSE:CVS) rating on Monday, November 2. JP Morgan has “Overweight” rating and $123 target.

The stock decreased 1.64% or $1.16 during the last trading session, reaching $69.39. About 16.72 million shares traded or 73.83% up from the average. CVS Health Corporation (NYSE:CVS) has declined 24.40% since February 11, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. The company has market cap of $70.30 billion. It operates through Pharmacy Services and Retail/LTC divisions. It has a 14.3 P/E ratio. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Nasdaq.com which released: “CVS Health Corp. Q4 Income Rises” on February 08, 2018, also Fool.com with their article: “Is CVS Health Corporation a Buy in 2018?” published on January 17, 2018, Seekingalpha.com published: “CVS Health Reminds Us That Investing Is 90% Half Common Sense” on January 18, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Fool.com and their article: “Tax Reform Lifts CVS Health Corporation in 4th Quarter, but Dents Its 2018 Outlook” published on February 08, 2018 as well as Nasdaq.com‘s news article titled: “CVS Health is Oversold” with publication date: February 09, 2018.